Thu, April 14, 2011
Wed, April 13, 2011
Tue, April 12, 2011
Mon, April 11, 2011
Sun, April 10, 2011
Sat, April 9, 2011
Fri, April 8, 2011
Thu, April 7, 2011
[ Thu, Apr 07th 2011 ]: Market Wire
Volunteering Does a Body Good
Wed, April 6, 2011
Tue, April 5, 2011
Mon, April 4, 2011
Sun, April 3, 2011
Sat, April 2, 2011
Fri, April 1, 2011
Thu, March 31, 2011
Wed, March 30, 2011
Tue, March 29, 2011
Mon, March 28, 2011
Sun, March 27, 2011
Fri, March 25, 2011
Thu, March 24, 2011

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspir


  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. es-of-fiduciary-duty-by-the-board-of-inspir.html
  Print publication without navigation Published in Health and Fitness on by Market Wire


NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of Inspire Pharmaceuticals, Inc. (aInspirea or the aCompanya) (Nasdaq: ISPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Merck (NYSE: MRK). Under the terms of the transaction, Inspire shareholders will receive $5.00 in cash per share of Inspire outstanding stock they own. The transaction has a total value of approximately $430 million.

Click here to learn how to join the action: [ http://www.zlk.com/inspire-pharmaceuticals-isph.html ], or call: 877-363-5972.

The investigation concerns whether the Inspire Board of Directors breached their fiduciary duties to Inspire stockholders by failing to adequately shop the Company before entering into this transaction and whether Merck is underpaying for Inspire shares, thus unlawfully harming Inspire stockholders. In particular, the mean price target set by five analysts for Inspire stock is $5.95 per share and at least one analyst set a price target of $10.00 per share.

If you own common stock in Inspire and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit [ http://www.zlk.com/inspire-pharmaceuticals-isph.html ].

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear